The venture was found in Europe in Switzerland. The main department of described VC is located in the Plan-les-ouates.
We can highlight the next thriving fund investment areas, such as Biotechnology, Collaboration. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Hylomorph, Augurix, Viroblock Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The real fund results show that this VC is 42 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2019. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Fongit Seed Invest, startups are often financed by Venture Kick, MassChallenge Switzerland, Initiative Capital Romandie. The meaningful sponsors for the fund in investment in the same round are investiere | Verve Capital Partners, Zu00fcrcher Kantonal Bank, StartAngels Network. In the next rounds fund is usually obtained by BlueOcean Ventures, investiere | Verve Capital Partners, Zu00fcrcher Kantonal Bank.
Related Funds
Fund Name | Location |
B2 Investment Group | California, San Diego, United States |
Dekrypt Capital | Berkeley, California, United States |
Fight Against Cancer Innovation Trust | - |
Garage Capital | Canada, Ontario, Waterloo |
GetThere | Southlake, Texas, United States |
Kuwait Investment Authority | Al Kuwayt, Kuwait |
Paralink Capital Management | - |
Wafra international investment | Al Asimah, Al Kuwayt, Kuwait |
Zhejiang Reclaim Construction Group | China, Ningbo, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Annaida Technologies | $1M | 09 Apr 2020 | Lausanne, Vaud, Switzerland | ||
EBAMed | $1M | 21 Aug 2019 | Geneva, Switzerland | ||
Gmelius | 02 May 2019 | Geneva, Geneva, Switzerland | |||
Hylomorph | $3M | 14 Sep 2018 | Zurich, Zurich, Switzerland | ||
Medyria | $2M | 30 Jan 2015 | Winterthur, Zurich, Switzerland | ||
Abionic | $2M | 26 Apr 2012 | Lausanne, Vaud, Switzerland | ||
Viroblock | 05 Feb 2010 | Geneva, Switzerland | |||
Viroblock | 20 Jul 2007 | Geneva, Switzerland | |||
Augurix | 20 Oct 2006 | Wallis, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Annaida Technologies | $1M | 09 Apr 2020 | Lausanne, Vaud, Switzerland | ||
EBAMed | $1M | 21 Aug 2019 | Geneva, Switzerland | ||
Gmelius | 02 May 2019 | Geneva, Geneva, Switzerland | |||
Hylomorph | $3M | 14 Sep 2018 | Zurich, Zurich, Switzerland | ||
Medyria | $2M | 30 Jan 2015 | Winterthur, Zurich, Switzerland | ||
Abionic | $2M | 26 Apr 2012 | Lausanne, Vaud, Switzerland | ||
Viroblock | 05 Feb 2010 | Geneva, Switzerland | |||
Viroblock | 20 Jul 2007 | Geneva, Switzerland | |||
Augurix | 20 Oct 2006 | Wallis, Switzerland |